Contrast induced nephropathy in percutaneous coronary interventions – Risk prediction and clinical outcomes

Contrast induced nephropathy in percutaneous coronary interventions – Risk prediction and clinical outcomes

Bibliographic Details
Main Authors:	Ashutosh Kumar, Hrishikesh Desle, G. Kiran, Srikar Sameer, Prasanth
Format:	Article
Language:	English
Published:	Elsevier 2014-11-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483214005719

Similar Items

Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention
by: Suma M. Victor, et al.
Published: (2014-09-01)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
by: Sana Shoukat, et al.
Published: (2010-01-01)

Incidence, Risk Factors, and Outcomes of Contrast Associated Nephropathy following Percutaneous Coronary Intervention
by: Iqbal Wani, et al.
Published: (2020-01-01)

Risk score for contrast induced nephropathy following percutaneous coronary intervention
by: Ghani Amal, et al.
Published: (2009-01-01)

Study of ECG findings in patients with normal CAG
by: Ashutosh kumar, et al.
Published: (2014-11-01)

The effect of remote ischaemic preconditioning on contrast induced nephropathy in the clinical setting of coronary angiography and percutaneous coronary intervention
by: Rear, Roger
Published: (2017)

Hyperuricemia may be related to contrast-induced nephropathy after percutaneous coronary intervention
by: Sait Demirkol, et al.
Published: (2013-07-01)

Fibrinogen-to-Albumin Ratio Predicts Contrast-Induced Nephropathy in Patients after Emergency Percutaneous Coronary Intervention
by: Zhebin You, et al.
Published: (2019-01-01)

RISK FACTORS FOR DEVELOPMENT OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: Ikram Ullah, et al.
Published: (2017-07-01)

Contrast induced nephropathy in very elderly patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Vipin Thomas, et al.
Published: (2017-11-01)

The Predictive Value of Myeloperoxidase for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
by: Yan G, et al.
Published: (2021-04-01)

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review
by: Jerzy Sacha, et al.
Published: (2019-06-01)

CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions
by: Ruey-Hsing Chou, et al.
Published: (2016-07-01)

The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention
by: Jingjing Zhao, et al.
Published: (2020-01-01)

Predicting contrast-induced nephropathy after percutaneous coronary intervention: Do we need formulas? A cardiological perspective
by: Marinella Patrizia Centemero, et al.
Published: (2018-01-01)

Original paper<br>Prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary interventions in everyday clinical practice
by: Hanna Bachórzewska-Gajewska, et al.
Published: (2006-12-01)

Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Mohamed Khalfallah, et al.
Published: (2021-08-01)

Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Boqian Zhu, et al.
Published: (2016-01-01)

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
by: H. Zhang, et al.
Published: (2021-06-01)

Predictive value of oxidant and antioxidant status for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction
by: Fatih Aksoy, et al.
Published: (2021-07-01)

Predictive value of oxidant and antioxidant status for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction
by: Fatih Aksoy, et al.
Published: (2021-07-01)

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
by: Jun-yi Zhang, et al.
Published: (2019-07-01)

The Role of Diuretics and Angiotensin-converting enzyme inhibitors on Contrast- Induced Nephropathy in Patients after Percutaneous Coronary Intervention
by: Alireza Dadpey, et al.
Published: (2007-12-01)

Predictors of contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
by: Mohamed Abdel-Ghany, et al.
Published: (2021-06-01)

Study of clinical presentation in patients with LMCA disease
by: Ashutosh Kumar, et al.
Published: (2014-11-01)

Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Rong Yang, et al.
Published: (2014-01-01)

Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention
by: Guoqiang Gu, et al.
Published: (2019-06-01)

Determinants of clinical outcomes following primary percutaneous coronary intervention : the West Yorkshire Primary Percutaneous Coronary Intervention Outcome Study
by: Krishnamurthy, Arvindra
Published: (2017)

Percutaneous coronary intervention in asians- are there differences in clinical outcome?
by: Chua Terrance S, et al.
Published: (2011-05-01)

140 INCIDENCE AND RISK FACTORS FOR CONTRAST INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION AT A TERTIARY CENTRE
by: A.A. Azrini, et al.
Published: (2017-08-01)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
by: Ata Firouzi, et al.
Published: (2018-09-01)

Predicting contrast induced nephropathy post coronary intervention: A prospective cohort study
by: Hamdy Shams-Eddin Taher, et al.
Published: (2015-12-01)

Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes
by: Zh D Kobalava, et al.
Published: (2015-06-01)

Contrast-induced thrombocytopenia following percutaneous coronary intervention
by: Roberto Muniz Ferreira, et al.
Published: (2017-07-01)

The role of thiol levels in predicting contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
by: Ahmet Korkmaz, et al.
Published: (2019-09-01)

CKD-EPI versus Cockcroft-Gault formula for predicting contrast-induced nephropathy following percutaneous coronary intervention in patients without significant renal impairment
by: Mário B.G. Nunes, et al.
Published: (2018-01-01)

Nephroprotective Effects of L-Carnitine against Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Open-Labeled Clinical Trial
by: Mohammad Mohammadi, et al.
Published: (2017-05-01)

Relationship between red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention
by: Dursun Çayan Akkoyun, et al.
Published: (2015-11-01)

Editöre Mektup - Red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention
by: Somsri Wiwanitkit, et al.
Published: (2016-04-01)

Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
by: Chengchun Tang, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_68s5h5uedun46jf2u1ij0e50qe